An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma.
暂无分享,去创建一个
P. LoRusso | N. Sanai | X. Bao | Jianmei Wu | Jing Li
[1] J. Sarkaria,et al. The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma , 2015, Clinical Cancer Research.
[2] W. Zeng,et al. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies , 2012, Analytical and Bioanalytical Chemistry.
[3] M. Matyska,et al. A new approach to bioanalysis: aqueous normal-phase chromatography with silica hydride stationary phases. , 2012, Bioanalysis.
[4] J. Aten,et al. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. , 2010, Cancer cell.
[5] J. Schellens,et al. Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents. , 2010, Current clinical pharmacology.
[6] P. LoRusso,et al. Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[7] Tsuyoshi Arai,et al. Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents , 2009, Molecular Cancer Therapeutics.
[8] Anders Tunek,et al. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. , 2007, Journal of medicinal chemistry.
[9] Chi-Tang Ho,et al. Separation of amino acids, peptides and corresponding Amadori compounds on a silica column at elevated temperature. , 2007, Journal of chromatography. A.
[10] T. Kanda,et al. Retention behavior of oligomeric proanthocyanidins in hydrophilic interaction chromatography. , 2007, Journal of chromatography. A.
[11] M. Hidalgo,et al. Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients , 2006, Investigational New Drugs.
[12] W. Naidong,et al. Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] A. Alpert. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. , 1990, Journal of chromatography.